Finnrick, an independent testing programme, publishes 41 assays for Tydes: 33 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 8 did not. Most recent assay 30 Apr 2025.
Tydes operates from US: NC, listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/tydes.
Finnrick-tested with poor results. Tested across 7 peptide products with 41 total samples.
Tydes is listed as active. Finnrick Grade D. Finnrick avg score: 5/10 across 41 samples (7 products). Below-average quality. Exercise caution.
Tydes holds independent lab grade D, assigned across 41 graded samples, average score 5/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
No independent third-party assay is on file for Tydes, and its storefront did not respond when we last tried to read it. An untested vendor has not failed a test — this is an absence of evidence, not evidence against it.
| Product | Assays | Result |
|---|---|---|
| Tirzepatide | 10 | 9 passed, 1 failed |
| Retatrutide | 9 | 8 passed, 1 failed |
| Semaglutide | 9 | 8 passed, 1 failed |
| BPC-157 | 5 | 2 passed, 3 failed |
| Melanotan II | 4 | 3 passed, 1 failed |
| Mazdutide | 3 | 3 passed, 0 failed |
| Ipamorelin | 1 | 0 passed, 1 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | D (41 samples) |
| Average grader score | 5/10 |
| Vendor type | Research-use supplier |
| Satisfaction | 0.5/5 |
|---|---|
| Delivery | 5/5 |
| Customer service | 5/5 |
| Packaging | 5/5 |
| Ease of purchase | 5/5 |
| Payment | 5/5 |
Scored out of 5 by the same independent grader, from its own buyers rather than from this site.
Tydes is listed as active and we hold 41 Finnrick assays (33 passing, 8 failing its purity threshold); an independent lab grade of D. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 41 assays for Tydes: 33 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 8 did not. Most recent assay 30 Apr 2025.
Similar vendors: SwissChems, Bfflink, Reta-Peptide, HkRoids, Zenith Jove Peptide ZJ, Shanghai Baoju, Heman Peptide HM, Allen Biotechnology Co ABC.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Tydes Research Peptides Review, UGL OZ Peptides Review, UGL OZ Shogun Peptides Review.